Scientists track patients closely to predict dangerous transplant complication
NCT ID NCT04188912
Summary
This study observed 267 adults who received stem cell transplants for blood cancers. Researchers collected samples and performed tests regularly for one year to learn how chronic graft-versus-host disease (GVHD) develops. The goal was to identify early warning signs that might help predict which patients will develop this serious complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
National Cancer Institute
Bethesda, Maryland, 20892, United States
-
Roswell Park
Buffalo, New York, 14263, United States
-
University of Florida
Gainesville, Florida, 32610, United States
-
Vanderbilt
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.